-
Something wrong with this record ?
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer
M. Abate, A. Lombardi, A. Luce, M. Porru, C. Leonetti, M. Bocchetti, V. Campani, G. De Rosa, SF. Graziano, V. Nele, F. Cardile, FZ. Marino, R. Franco, A. Ronchi, M. Scrima, R. Sperlongano, R. Alfano, G. Misso, E. Amler, M. Caraglia, S. Zappavigna
Status not-indexed Language English Country United States
Document type Journal Article
NLK
Directory of Open Access Journals
from 2012
Free Medical Journals
from 2000 to 1 year ago
PubMed Central
from 2012
Open Access Digital Library
from 2012-01-01
Open Access Digital Library
from 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2012
- Publication type
- Journal Article MeSH
Nanodiamonds are innovative nanocrystalline carbon particles able to deliver chemically conjugated miRNAs. In oncology, the use of miRNA-based therapies may represent an advantage, based on their ability to simultaneously target multiple intracellular oncogenic targets. Here, nanodiamonds were tested and optimized to deliver miR-34a, a miRNA playing a key role in inhibiting tumor development and progression in many cancers. The physical-chemical properties of nanodiamonds were investigated suggesting electrical stability and uniformity of structure and size. Moreover, we evaluated nanodiamond cytotoxicity on two breast cancer cell models and confirmed their excellent biocompatibility. Subsequently, nanodiamonds were conjugated with miR-34a, using the chemical crosslinker polyethyleneimine; real-time PCR analysis revealed a higher level of miR-34a in cancer cells treated with the different formulations of nanodiamonds than with commercial transfectant. A significant and early nanodiamond-miR-34a uptake was recorded by FACS and fluorescence microscopy analysis in MCF7 and MDA-MB-231 cells. Moreover, nanodiamond-miR-34a significantly inhibited both cell proliferation and migration. Finally, a remarkable anti-tumor effect of miR-34a-conjugated nanodiamonds was observed in both heterotopic and orthotopic murine xenograft models. In conclusion, this study provides a rationale for the development of new therapeutic strategies based on use of miR-34a delivered by nanodiamonds to improve the clinical treatment of neoplasms.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23015288
- 003
- CZ-PrNML
- 005
- 20231020093529.0
- 007
- ta
- 008
- 231010s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.omtn.2023.06.012 $2 doi
- 035 __
- $a (PubMed)37449042
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Abate, Marianna $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli," Via L. De Crecchio 7, 80138 Naples, Italy $u Institute of Biophysics, 2nd Faculty of Medicine, Charles University, V Uvalu 84, 15006 Prague, Czech Republic
- 245 10
- $a Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer / $c M. Abate, A. Lombardi, A. Luce, M. Porru, C. Leonetti, M. Bocchetti, V. Campani, G. De Rosa, SF. Graziano, V. Nele, F. Cardile, FZ. Marino, R. Franco, A. Ronchi, M. Scrima, R. Sperlongano, R. Alfano, G. Misso, E. Amler, M. Caraglia, S. Zappavigna
- 520 9_
- $a Nanodiamonds are innovative nanocrystalline carbon particles able to deliver chemically conjugated miRNAs. In oncology, the use of miRNA-based therapies may represent an advantage, based on their ability to simultaneously target multiple intracellular oncogenic targets. Here, nanodiamonds were tested and optimized to deliver miR-34a, a miRNA playing a key role in inhibiting tumor development and progression in many cancers. The physical-chemical properties of nanodiamonds were investigated suggesting electrical stability and uniformity of structure and size. Moreover, we evaluated nanodiamond cytotoxicity on two breast cancer cell models and confirmed their excellent biocompatibility. Subsequently, nanodiamonds were conjugated with miR-34a, using the chemical crosslinker polyethyleneimine; real-time PCR analysis revealed a higher level of miR-34a in cancer cells treated with the different formulations of nanodiamonds than with commercial transfectant. A significant and early nanodiamond-miR-34a uptake was recorded by FACS and fluorescence microscopy analysis in MCF7 and MDA-MB-231 cells. Moreover, nanodiamond-miR-34a significantly inhibited both cell proliferation and migration. Finally, a remarkable anti-tumor effect of miR-34a-conjugated nanodiamonds was observed in both heterotopic and orthotopic murine xenograft models. In conclusion, this study provides a rationale for the development of new therapeutic strategies based on use of miR-34a delivered by nanodiamonds to improve the clinical treatment of neoplasms.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lombardi, Angela $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli," Via L. De Crecchio 7, 80138 Naples, Italy
- 700 1_
- $a Luce, Amalia $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli," Via L. De Crecchio 7, 80138 Naples, Italy
- 700 1_
- $a Porru, Manuela $u Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, E Chianesi 53, 00144 Rome, Italy
- 700 1_
- $a Leonetti, Carlo $u Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, E Chianesi 53, 00144 Rome, Italy
- 700 1_
- $a Bocchetti, Marco $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli," Via L. De Crecchio 7, 80138 Naples, Italy $u Laboratory of Precision and Molecular Oncology, Biogem Scarl, Institute of Genetic Research, Contrada Camporeale, 83031 Ariano Irpino, Italy
- 700 1_
- $a Campani, Virginia $u Department of Pharmacy, University of Naples Federico II, D. Montesano 49, 80131 Naples, Italy
- 700 1_
- $a De Rosa, Giuseppe $u Department of Pharmacy, University of Naples Federico II, D. Montesano 49, 80131 Naples, Italy
- 700 1_
- $a Graziano, Sossio Fabio $u Department of Pharmacy, University of Naples Federico II, D. Montesano 49, 80131 Naples, Italy
- 700 1_
- $a Nele, Valeria $u Department of Pharmacy, University of Naples Federico II, D. Montesano 49, 80131 Naples, Italy
- 700 1_
- $a Cardile, Francesco $u Laboratory of Precision and Molecular Oncology, Biogem Scarl, Institute of Genetic Research, Contrada Camporeale, 83031 Ariano Irpino, Italy
- 700 1_
- $a Marino, Federica Zito $u Department of Mental and Physical Health and Preventive Medicine, Pathology Unit, University of Campania "Luigi Vanvitelli," 80138 Naples, Italy
- 700 1_
- $a Franco, Renato $u Department of Mental and Physical Health and Preventive Medicine, Pathology Unit, University of Campania "Luigi Vanvitelli," 80138 Naples, Italy
- 700 1_
- $a Ronchi, Andrea $u Department of Mental and Physical Health and Preventive Medicine, Pathology Unit, University of Campania "Luigi Vanvitelli," 80138 Naples, Italy
- 700 1_
- $a Scrima, Marianna $u Laboratory of Precision and Molecular Oncology, Biogem Scarl, Institute of Genetic Research, Contrada Camporeale, 83031 Ariano Irpino, Italy
- 700 1_
- $a Sperlongano, Rossella $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli," Via L. De Crecchio 7, 80138 Naples, Italy
- 700 1_
- $a Alfano, Roberto $u Department of Advanced Medical and Surgical Sciences "DAMSS," University of Campania "Luigi Vanvitelli," Via S. M. di Costantinopoli 104, 80138 Naples, Italy
- 700 1_
- $a Misso, Gabriella $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli," Via L. De Crecchio 7, 80138 Naples, Italy
- 700 1_
- $a Amler, Evzen $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli," Via L. De Crecchio 7, 80138 Naples, Italy $u Institute of Biophysics, 2nd Faculty of Medicine, Charles University, V Uvalu 84, 15006 Prague, Czech Republic
- 700 1_
- $a Caraglia, Michele $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli," Via L. De Crecchio 7, 80138 Naples, Italy $u Laboratory of Precision and Molecular Oncology, Biogem Scarl, Institute of Genetic Research, Contrada Camporeale, 83031 Ariano Irpino, Italy
- 700 1_
- $a Zappavigna, Silvia $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli," Via L. De Crecchio 7, 80138 Naples, Italy
- 773 0_
- $w MED00189560 $t Molecular therapy. Nucleic acids $x 2162-2531 $g Roč. 33, č. - (2023), s. 127-141
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37449042 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231010 $b ABA008
- 991 __
- $a 20231020093523 $b ABA008
- 999 __
- $a ok $b bmc $g 1997083 $s 1201650
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 33 $c - $d 127-141 $e 20230619 $i 2162-2531 $m Molecular therapy. Nucleic acids $n Mol Ther Nucleic Acids $x MED00189560
- LZP __
- $a Pubmed-20231010